The unique DNA methylation signatures demonstrated by the sporadic MLH1 methylated and constitutional MLH1 epimutation tumours were investigated in CRCs from carriers of a germline VUS in the MLH1 promoter or with tumour MLH1 methylation in an early-onset CRC (EOCRC) to support classification. Here, MLH1 is linked to neoplasm.